Provided by Tiger Trade Technology Pte. Ltd.

Spruce Biosciences, Inc.

53.86
-0.3000-0.55%
Post-market: 53.860.00000.00%19:30 EDT
Volume:135.27K
Turnover:7.40M
Market Cap:154.79M
PE:-1.40
High:57.11
Open:56.22
Low:53.28
Close:54.16
52wk High:240.00
52wk Low:7.26
Shares:2.87M
Float Shares:2.29M
Volume Ratio:1.30
T/O Rate:5.92%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-38.4300
EPS(LYR):-50.8298
ROE:-105.98%
ROA:-40.03%
PB:1.85
PE(LYR):-1.06

Loading ...

Spruce Biosciences - Bla Submission for Ta-Ert for Mps Iiib Anticipated in Q4 2026

THOMSON REUTERS
·
Aug 12

Spruce Biosciences Q2 EPS USD -6.68

THOMSON REUTERS
·
Aug 12

Spruce Biosciences Q2 Operating Expenses USD 16.512 Million

THOMSON REUTERS
·
Aug 12

Cure Sanfilippo Foundation, National MPS Society Invest $5.5 Million in Spruce Biosciences

Reuters
·
Aug 12

Spruce Biosciences, - Cure Sanfilippo Foundation and National Mps Society Invest $5.50 Mln in Spruce Biosciences

THOMSON REUTERS
·
Aug 12

Spruce Biosciences, - Ta-Ert Expanded Access Program Expected to Initiate in Q4 2026

THOMSON REUTERS
·
Aug 12

Spruce Biosciences, Inc. Expected to Post a Loss of $5.80 a Share - Earnings Preview

Reuters
·
Aug 10

Spruce Biosciences Names Jessica Cohen Pfeffer Vice President, Clinical Development

Reuters
·
Aug 03

Spruce Biosciences Appoints Jessica Cohen Pfeffer, M.d., as Vice President, Clinical Development

THOMSON REUTERS
·
Aug 03

Spruce Biosciences Moves Tralesinidase Alfa Into Phase 3, Putting Rare Disease Upside in Focus

TIPRANKS
·
Jul 31

Spruce Biosciences Files Form 3 for Chief Medical Officer Adrian W. Quartel

Reuters
·
Jul 30

Spruce Biosciences Names Adrian Quartel Chief Medical Officer

Reuters
·
Jul 27

Spruce Biosciences Appoints Adrian Quartel, M.d., Ffpm, as Chief Medical Officer

THOMSON REUTERS
·
Jul 27

Spruce Biosciences Initiated at Buy by B. Riley Securities

Dow Jones
·
Jul 13

B. Riley Initiates Spruce Biosciences at Buy With $160 Price Target

MT Newswires Live
·
Jul 13

Spruce Biosciences, Inc : B. Riley Initiates Coverage with Buy Rating; Target Price $160

THOMSON REUTERS
·
Jul 13

Spruce Biosciences joins Russell 3000 Index

TIPRANKS
·
Jun 29

Spruce Biosciences names Agnieszka Jurecka vice president, medical affairs

Reuters
·
Jun 22

Spruce Biosciences Appoints Agnieszka Jurecka, M.d., Ph.d., Mph, as Vice President, Medical Affairs

THOMSON REUTERS
·
Jun 22

Spruce Biosciences Initiated at Buy by Guggenheim

Dow Jones
·
Jun 16